Cargando…
Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease
Although the epigenetic regulatory protein histone deacetylase 6 (HDAC6) has been recently implicated in the etiology of Alzheimer's disease (AD), little is known about the role of HDAC6 in the etiopathogenesis of AD and whether HDAC6 can be a potential therapeutic target for AD. Here, we perfo...
Autores principales: | Bai, Ping, Mondal, Prasenjit, Bagdasarian, Frederick A., Rani, Nisha, Liu, Yan, Gomm, Ashley, Tocci, Darcy R., Choi, Se Hoon, Wey, Hsiao-Ying, Tanzi, Rudolph E., Zhang, Can, Wang, Changning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532562/ https://www.ncbi.nlm.nih.gov/pubmed/36213537 http://dx.doi.org/10.1016/j.apsb.2022.05.017 |
Ejemplares similares
-
[(11)C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2022) -
Molecular imaging of Alzheimer’s disease–related gamma-secretase in mice and nonhuman primates
por: Xu, Yulong, et al.
Publicado: (2020) -
Author Correction: [(11)C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2022) -
In Vivo Imaging of Histone
Deacetylases (HDACs) in
the Central Nervous System and Major Peripheral Organs
por: Wang, Changning, et al.
Publicado: (2014) -
Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer’s disease-related neuropathology in cell models
por: Zhang, Siyi, et al.
Publicado: (2022)